Evidence map›Paper›PMID 41271783›Full record

ArticleNPJ Parkinson's disease2025

Author Correction: Classification of GBA1 variants and their impact on Parkinson's disease: an in silico score analysis.

Aymeric Lanore, Christelle Tesson, Aymeric Basset, François-Xavier Lejeune, Guillaume Cogan, Graziella Mangone, Sara Sambin, Nathalie Bertille, Mathieu Anheim, Isabelle Arnulf and 25 more

Abstract readPublished Erratum
In one paragraph

Article in NPJ Parkinson's disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

35 authors.

Aymeric LanoreSorbonne Université, Institut du Cerveau - Paris Brain Institute - ICM, Inserm, CNRS, Assistance Publique Hôpitaux de Paris, NS-Park/FCRIN network, Department of Neurology, CIC Neurosciences, Hôpital Pitié-Salpêtrière, Paris, France. aymeric.lanore@icm-institute.org.
Christelle TessonSorbonne Université, Institut du Cerveau - Paris Brain Institute - ICM, Inserm, CNRS, Assistance Publique Hôpitaux de Paris, NS-Park/FCRIN network, Department of Neurology, CIC Neurosciences, Hôpital Pitié-Salpêtrière, Paris, France.
Aymeric BassetSorbonne Université, Institut du Cerveau - Paris Brain Institute - ICM, Inserm, CNRS, Assistance Publique Hôpitaux de Paris, NS-Park/FCRIN network, Department of Neurology, CIC Neurosciences, Hôpital Pitié-Salpêtrière, Paris, France.
François-Xavier LejeuneSorbonne Université, Institut du Cerveau - Paris Brain Institute - ICM, Inserm, CNRS, Assistance Publique Hôpitaux de Paris, NS-Park/FCRIN network, Department of Neurology, CIC Neurosciences, Hôpital Pitié-Salpêtrière, Paris, France.
Guillaume CoganSorbonne Université, Institut du Cerveau - Paris Brain Institute - ICM, Inserm, CNRS, Assistance Publique Hôpitaux de Paris, NS-Park/FCRIN network, Department of Neurology, CIC Neurosciences, Hôpital Pitié-Salpêtrière, Paris, France.
Graziella MangoneSorbonne Université, Institut du Cerveau - Paris Brain Institute - ICM, Inserm, CNRS, Assistance Publique Hôpitaux de Paris, NS-Park/FCRIN network, Department of Neurology, CIC Neurosciences, Hôpital Pitié-Salpêtrière, Paris, France.
Sara SambinSorbonne Université, Institut du Cerveau - Paris Brain Institute - ICM, Inserm, CNRS, Assistance Publique Hôpitaux de Paris, NS-Park/FCRIN network, Department of Neurology, CIC Neurosciences, Hôpital Pitié-Salpêtrière, Paris, France.
Nathalie BertilleCAP-HP, Hôpital Pitié Salpêtrière, Centre de Pharmacoépidémiologie (Cephepi), Paris, France.
Mathieu AnheimDepartment of Neurology, Neurogenetic Reference Centre, Parkinson's Expert Centre, University Hospitals of Strasbourg, Strasbourg, France.
Isabelle ArnulfSorbonne Université, Institut du Cerveau - Paris Brain Institute - ICM, Inserm, CNRS, Assistance Publique Hôpitaux de Paris, NS-Park/FCRIN network, Department of Neurology, CIC Neurosciences, Hôpital Pitié-Salpêtrière, Paris, France.
Solène AnsquerNeurology Department, Centre Expert Parkinson, CIC-INSERM 1402, CHU Poitiers, Poitiers, NS-PARK/FCRIN Network, France.
Jean-Philippe BrandelHôpital Fondation Ophtalmologique A de Rothschild, Unité James Parkisnon, NS-PARK/FCRIN Network, Paris, France.
Christine Brefel-CourbonClinical Investigation Center CIC1436, Parkinson Expert Center, Department of Clinical, Pharmacology and Neuroscience, NS-Park/FCRIN network, NeuroToul COEN Center; Toulouse, University Hospital, INSERM and University of Toulouse 3, Toulouse, France.
Luc DefebvreParkinson's Disease Center of Excellence, Department of Neurology, University of Lille, CHU Lille, INSERM U1172- Degenerative & Vascular Cognitive Disorders, Lille, France.
Sophie DrapierPontchaillou University Hospital, Department of Neurology, CIC INSERM 1414, Rennes, France.
Alexandre EusebsioAix Marseille Université, AP-HM, Hôpital de La Timone, Service de Neurologie et Pathologie du Mouvement, Rennes, France.
Margherita FabbriClinical Investigation Center CIC1436, Parkinson Expert Center, Department of Clinical, Pharmacology and Neuroscience, NS-Park/FCRIN network, NeuroToul COEN Center; Toulouse, University Hospital, INSERM and University of Toulouse 3, Toulouse, France.
Caroline GiordanaNeurology Department, NS-Park/FCRIN network, Centre Hospitalier Universitaire de Nice, Université Côte d'Azur, Nice, France.
Elodie HainqueSorbonne Université, Institut du Cerveau - Paris Brain Institute - ICM, Inserm, CNRS, Assistance Publique Hôpitaux de Paris, NS-Park/FCRIN network, Department of Neurology, CIC Neurosciences, Hôpital Pitié-Salpêtrière, Paris, France.
Stephane LehericyAssistance Publique Hôpitaux de Paris, Department of Neuroradiology, Hôpital Pitié-Salpêtrière, Paris, France.
Ana MarquesUniversité Clermont Auvergne, IGCNC, Department of Neurology, Parkinson expert center, CHU Clermont-Ferrand, Clermont-Ferrand, France.
Caroline MoreauParkinson's Disease Center of Excellence, Department of Neurology, University of Lille, CHU Lille, INSERM U1172- Degenerative & Vascular Cognitive Disorders, Lille, France.
Elena MoroGrenoble Alpes University, Movement Disorders Unit, Division of Neurology, CHU de Grenoble, Grenoble Institute of Neurosciences, Grenoble, France.
Fabienne OryClinical Investigation Center CIC1436, Parkinson Expert Center, Department of Clinical, Pharmacology and Neuroscience, NS-Park/FCRIN network, NeuroToul COEN Center; Toulouse, University Hospital, INSERM and University of Toulouse 3, Toulouse, France.
Anne-Sophie RollandDepartment of Medical Pharmacology, CHU Lille, University of Lille, Lille Neuroscience & Cognition, INSERM, UMR-S1172, LICEND, NS-Park/F-CRIN network, Lille, France.
Stéphane ThoboisHospices Civils de Lyon, Hôpital Neurologique Pierre Wertheimer, Department of Neurology C, NS-Park/FCRIN network, Univ Lyon, Université Claude Bernard Lyon 1, Faculté de Médecine Lyon Sud Charles Mérieux, Lyon, France; INSERM, Centre de Recherche en Neurosciences de Lyon, PATH-PARK, Bron, France.
Marie VidailhetSorbonne Université, Institut du Cerveau - Paris Brain Institute - ICM, Inserm, CNRS, Assistance Publique Hôpitaux de Paris, NS-Park/FCRIN network, Department of Neurology, CIC Neurosciences, Hôpital Pitié-Salpêtrière, Paris, France.
David DevosDepartment of Medical Pharmacology, CHU Lille, University of Lille, Lille Neuroscience & Cognition, INSERM, UMR-S1172, LICEND, NS-Park/F-CRIN network, Lille, France.
Louise-Laure MarianiSorbonne Université, Institut du Cerveau - Paris Brain Institute - ICM, Inserm, CNRS, Assistance Publique Hôpitaux de Paris, NS-Park/FCRIN network, Department of Neurology, CIC Neurosciences, Hôpital Pitié-Salpêtrière, Paris, France.
Suzanne LesageSorbonne Université, Institut du Cerveau - Paris Brain Institute - ICM, Inserm, CNRS, Assistance Publique Hôpitaux de Paris, NS-Park/FCRIN network, Department of Neurology, CIC Neurosciences, Hôpital Pitié-Salpêtrière, Paris, France.
Alexis BriceSorbonne Université, Institut du Cerveau - Paris Brain Institute - ICM, Inserm, CNRS, Assistance Publique Hôpitaux de Paris, NS-Park/FCRIN network, Department of Neurology, CIC Neurosciences, Hôpital Pitié-Salpêtrière, Paris, France.
Jean-Christophe CorvolSorbonne Université, Institut du Cerveau - Paris Brain Institute - ICM, Inserm, CNRS, Assistance Publique Hôpitaux de Paris, NS-Park/FCRIN network, Department of Neurology, CIC Neurosciences, Hôpital Pitié-Salpêtrière, Paris, France.
Predistim study group
Iceberg study group
NSPark study group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41271783
PMCPMC12639121

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.